nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—CYP2C9—brain cancer	0.515	1	CbGaD
Nelfinavir—CYP2D6—Lomustine—brain cancer	0.0536	0.147	CbGbCtD
Nelfinavir—CYP1A2—Carmustine—brain cancer	0.053	0.146	CbGbCtD
Nelfinavir—ABCG2—Carboplatin—brain cancer	0.0454	0.125	CbGbCtD
Nelfinavir—CYP2D6—Hydroxyurea—brain cancer	0.0406	0.112	CbGbCtD
Nelfinavir—CYP3A4—Temozolomide—brain cancer	0.0401	0.11	CbGbCtD
Nelfinavir—ABCG2—Etoposide—brain cancer	0.0381	0.105	CbGbCtD
Nelfinavir—CYP3A4—Lomustine—brain cancer	0.0341	0.0937	CbGbCtD
Nelfinavir—CYP3A5—Etoposide—brain cancer	0.0211	0.0581	CbGbCtD
Nelfinavir—CYP1A2—Etoposide—brain cancer	0.0157	0.0432	CbGbCtD
Nelfinavir—ABCB1—Etoposide—brain cancer	0.0137	0.0378	CbGbCtD
Nelfinavir—CYP3A4—Etoposide—brain cancer	0.00824	0.0226	CbGbCtD
Nelfinavir—Indinavir—CYP2C9—brain cancer	0.00186	0.573	CrCbGaD
Nelfinavir—Saquinavir—CYP2C9—brain cancer	0.00139	0.427	CrCbGaD
Nelfinavir—Rash maculo-papular—Hydroxyurea—brain cancer	0.000864	0.00892	CcSEcCtD
Nelfinavir—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.000857	0.0399	CbGpPWpGaD
Nelfinavir—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000835	0.0389	CbGpPWpGaD
Nelfinavir—Hyperbilirubinaemia—Temozolomide—brain cancer	0.000816	0.00844	CcSEcCtD
Nelfinavir—Hepatic enzyme increased—Temozolomide—brain cancer	0.000785	0.00811	CcSEcCtD
Nelfinavir—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00076	0.0354	CbGpPWpGaD
Nelfinavir—Leukopenia—Lomustine—brain cancer	0.000757	0.00782	CcSEcCtD
Nelfinavir—Pancreatitis—Procarbazine—brain cancer	0.000755	0.0078	CcSEcCtD
Nelfinavir—Dermatitis bullous—Hydroxyurea—brain cancer	0.000722	0.00746	CcSEcCtD
Nelfinavir—CYP3A7—Xenobiotics—CYP2C9—brain cancer	0.000718	0.0334	CbGpPWpGaD
Nelfinavir—Pneumonia—Procarbazine—brain cancer	0.000691	0.00714	CcSEcCtD
Nelfinavir—Thrombocytopenia—Lomustine—brain cancer	0.000676	0.00698	CcSEcCtD
Nelfinavir—Pain—Carboplatin—brain cancer	0.000675	0.00697	CcSEcCtD
Nelfinavir—Jaundice—Procarbazine—brain cancer	0.00067	0.00692	CcSEcCtD
Nelfinavir—Stomatitis—Procarbazine—brain cancer	0.00067	0.00692	CcSEcCtD
Nelfinavir—Sweating—Procarbazine—brain cancer	0.000659	0.0068	CcSEcCtD
Nelfinavir—Anorexia—Lomustine—brain cancer	0.000658	0.0068	CcSEcCtD
Nelfinavir—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000651	0.0303	CbGpPWpGaD
Nelfinavir—Epistaxis—Procarbazine—brain cancer	0.000648	0.00669	CcSEcCtD
Nelfinavir—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000648	0.0301	CbGpPWpGaD
Nelfinavir—Diabetes mellitus—Carmustine—brain cancer	0.000641	0.00662	CcSEcCtD
Nelfinavir—Hyperuricaemia—Etoposide—brain cancer	0.00064	0.00662	CcSEcCtD
Nelfinavir—Body temperature increased—Carboplatin—brain cancer	0.000624	0.00644	CcSEcCtD
Nelfinavir—Haemoglobin—Procarbazine—brain cancer	0.00062	0.0064	CcSEcCtD
Nelfinavir—Haemorrhage—Procarbazine—brain cancer	0.000617	0.00637	CcSEcCtD
Nelfinavir—Inflammation—Etoposide—brain cancer	0.000612	0.00633	CcSEcCtD
Nelfinavir—Injury—Carmustine—brain cancer	0.000607	0.00627	CcSEcCtD
Nelfinavir—Blood uric acid increased—Etoposide—brain cancer	0.000605	0.00625	CcSEcCtD
Nelfinavir—Decreased appetite—Lomustine—brain cancer	0.0006	0.0062	CcSEcCtD
Nelfinavir—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000596	0.0277	CbGpPWpGaD
Nelfinavir—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000592	0.0276	CbGpPWpGaD
Nelfinavir—Pancreatitis—Hydroxyurea—brain cancer	0.000585	0.00604	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.000558	0.00576	CcSEcCtD
Nelfinavir—Neutropenia—Hydroxyurea—brain cancer	0.000558	0.00576	CcSEcCtD
Nelfinavir—Body temperature increased—Lomustine—brain cancer	0.000546	0.00564	CcSEcCtD
Nelfinavir—Rash maculo-papular—Etoposide—brain cancer	0.00054	0.00558	CcSEcCtD
Nelfinavir—Mouth ulceration—Etoposide—brain cancer	0.000537	0.00555	CcSEcCtD
Nelfinavir—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000531	0.0247	CbGpPWpGaD
Nelfinavir—Affect lability—Temozolomide—brain cancer	0.00053	0.00548	CcSEcCtD
Nelfinavir—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000519	0.0242	CbGpPWpGaD
Nelfinavir—Stomatitis—Hydroxyurea—brain cancer	0.000518	0.00535	CcSEcCtD
Nelfinavir—Liver function test abnormal—Carmustine—brain cancer	0.000515	0.00532	CcSEcCtD
Nelfinavir—Mood swings—Temozolomide—brain cancer	0.000511	0.00527	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000503	0.00519	CcSEcCtD
Nelfinavir—Dehydration—Temozolomide—brain cancer	0.000501	0.00518	CcSEcCtD
Nelfinavir—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000499	0.0232	CbGpPWpGaD
Nelfinavir—Anaemia—Procarbazine—brain cancer	0.000496	0.00513	CcSEcCtD
Nelfinavir—Muscular weakness—Carmustine—brain cancer	0.000492	0.00508	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000485	0.00501	CcSEcCtD
Nelfinavir—Leukopenia—Procarbazine—brain cancer	0.000481	0.00496	CcSEcCtD
Nelfinavir—Haemoglobin—Hydroxyurea—brain cancer	0.00048	0.00496	CcSEcCtD
Nelfinavir—Haemorrhage—Hydroxyurea—brain cancer	0.000477	0.00493	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000475	0.00491	CcSEcCtD
Nelfinavir—Muscular weakness—Temozolomide—brain cancer	0.000475	0.00491	CcSEcCtD
Nelfinavir—Abdominal distension—Temozolomide—brain cancer	0.000469	0.00484	CcSEcCtD
Nelfinavir—Convulsion—Procarbazine—brain cancer	0.000465	0.00481	CcSEcCtD
Nelfinavir—Myalgia—Procarbazine—brain cancer	0.000457	0.00472	CcSEcCtD
Nelfinavir—Arthralgia—Procarbazine—brain cancer	0.000457	0.00472	CcSEcCtD
Nelfinavir—Anxiety—Procarbazine—brain cancer	0.000455	0.00471	CcSEcCtD
Nelfinavir—Neutropenia—Carmustine—brain cancer	0.000451	0.00466	CcSEcCtD
Nelfinavir—Vomiting—Lomustine—brain cancer	0.000439	0.00453	CcSEcCtD
Nelfinavir—Oedema—Procarbazine—brain cancer	0.000438	0.00453	CcSEcCtD
Nelfinavir—Neutropenia—Temozolomide—brain cancer	0.000436	0.0045	CcSEcCtD
Nelfinavir—Hyperglycaemia—Carmustine—brain cancer	0.000435	0.00449	CcSEcCtD
Nelfinavir—Angiopathy—Hydroxyurea—brain cancer	0.000433	0.00447	CcSEcCtD
Nelfinavir—Pneumonia—Carmustine—brain cancer	0.000432	0.00447	CcSEcCtD
Nelfinavir—Thrombocytopenia—Procarbazine—brain cancer	0.000429	0.00443	CcSEcCtD
Nelfinavir—Hyperhidrosis—Procarbazine—brain cancer	0.000424	0.00438	CcSEcCtD
Nelfinavir—Hyperglycaemia—Temozolomide—brain cancer	0.00042	0.00434	CcSEcCtD
Nelfinavir—Stomatitis—Carmustine—brain cancer	0.000419	0.00433	CcSEcCtD
Nelfinavir—Pneumonia—Temozolomide—brain cancer	0.000418	0.00432	CcSEcCtD
Nelfinavir—Anorexia—Procarbazine—brain cancer	0.000418	0.00431	CcSEcCtD
Nelfinavir—Erythema—Hydroxyurea—brain cancer	0.000415	0.00429	CcSEcCtD
Nelfinavir—Nausea—Lomustine—brain cancer	0.00041	0.00423	CcSEcCtD
Nelfinavir—Stomatitis—Temozolomide—brain cancer	0.000405	0.00418	CcSEcCtD
Nelfinavir—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000401	0.0187	CbGpPWpGaD
Nelfinavir—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000399	0.00412	CcSEcCtD
Nelfinavir—Insomnia—Procarbazine—brain cancer	0.000396	0.00409	CcSEcCtD
Nelfinavir—Paraesthesia—Procarbazine—brain cancer	0.000393	0.00406	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Temozolomide—brain cancer	0.000393	0.00406	CcSEcCtD
Nelfinavir—Sinusitis—Temozolomide—brain cancer	0.00039	0.00403	CcSEcCtD
Nelfinavir—Somnolence—Procarbazine—brain cancer	0.000389	0.00402	CcSEcCtD
Nelfinavir—Cramp muscle—Etoposide—brain cancer	0.000388	0.00401	CcSEcCtD
Nelfinavir—Haemoglobin—Carmustine—brain cancer	0.000388	0.00401	CcSEcCtD
Nelfinavir—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000386	0.018	CbGpPWpGaD
Nelfinavir—Haemorrhage—Carmustine—brain cancer	0.000386	0.00399	CcSEcCtD
Nelfinavir—Ill-defined disorder—Hydroxyurea—brain cancer	0.000385	0.00398	CcSEcCtD
Nelfinavir—Anaemia—Hydroxyurea—brain cancer	0.000384	0.00397	CcSEcCtD
Nelfinavir—Decreased appetite—Procarbazine—brain cancer	0.000381	0.00393	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Etoposide—brain cancer	0.00038	0.00393	CcSEcCtD
Nelfinavir—Connective tissue disorder—Carmustine—brain cancer	0.000379	0.00392	CcSEcCtD
Nelfinavir—Haemoglobin—Temozolomide—brain cancer	0.000375	0.00387	CcSEcCtD
Nelfinavir—Malaise—Hydroxyurea—brain cancer	0.000375	0.00387	CcSEcCtD
Nelfinavir—Pain—Procarbazine—brain cancer	0.000375	0.00387	CcSEcCtD
Nelfinavir—Haemorrhage—Temozolomide—brain cancer	0.000373	0.00385	CcSEcCtD
Nelfinavir—Hepatitis—Temozolomide—brain cancer	0.000373	0.00385	CcSEcCtD
Nelfinavir—Leukopenia—Hydroxyurea—brain cancer	0.000372	0.00384	CcSEcCtD
Nelfinavir—Pharyngitis—Temozolomide—brain cancer	0.00037	0.00382	CcSEcCtD
Nelfinavir—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000369	0.0172	CbGpPWpGaD
Nelfinavir—Bronchospasm—Etoposide—brain cancer	0.000367	0.00379	CcSEcCtD
Nelfinavir—Connective tissue disorder—Temozolomide—brain cancer	0.000366	0.00379	CcSEcCtD
Nelfinavir—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000365	0.017	CbGpPWpGaD
Nelfinavir—Feeling abnormal—Procarbazine—brain cancer	0.000361	0.00373	CcSEcCtD
Nelfinavir—Eye disorder—Carmustine—brain cancer	0.000361	0.00372	CcSEcCtD
Nelfinavir—Convulsion—Hydroxyurea—brain cancer	0.00036	0.00372	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Procarbazine—brain cancer	0.000358	0.0037	CcSEcCtD
Nelfinavir—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000356	0.0166	CbGpPWpGaD
Nelfinavir—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000355	0.0165	CbGpPWpGaD
Nelfinavir—Erythema multiforme—Temozolomide—brain cancer	0.000353	0.00364	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000351	0.00363	CcSEcCtD
Nelfinavir—Discomfort—Hydroxyurea—brain cancer	0.000349	0.00361	CcSEcCtD
Nelfinavir—Neutropenia—Etoposide—brain cancer	0.000349	0.0036	CcSEcCtD
Nelfinavir—Eye disorder—Temozolomide—brain cancer	0.000348	0.0036	CcSEcCtD
Nelfinavir—Urticaria—Procarbazine—brain cancer	0.000348	0.0036	CcSEcCtD
Nelfinavir—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000347	0.0162	CbGpPWpGaD
Nelfinavir—Abdominal pain—Procarbazine—brain cancer	0.000346	0.00358	CcSEcCtD
Nelfinavir—Body temperature increased—Procarbazine—brain cancer	0.000346	0.00358	CcSEcCtD
Nelfinavir—Oedema—Hydroxyurea—brain cancer	0.000339	0.0035	CcSEcCtD
Nelfinavir—Angiopathy—Temozolomide—brain cancer	0.000338	0.00349	CcSEcCtD
Nelfinavir—Immune system disorder—Temozolomide—brain cancer	0.000337	0.00348	CcSEcCtD
Nelfinavir—Erythema—Carmustine—brain cancer	0.000336	0.00347	CcSEcCtD
Nelfinavir—Malnutrition—Carmustine—brain cancer	0.000336	0.00347	CcSEcCtD
Nelfinavir—Pneumonia—Etoposide—brain cancer	0.000334	0.00345	CcSEcCtD
Nelfinavir—Thrombocytopenia—Hydroxyurea—brain cancer	0.000332	0.00343	CcSEcCtD
Nelfinavir—Skin disorder—Hydroxyurea—brain cancer	0.000329	0.0034	CcSEcCtD
Nelfinavir—Back pain—Carmustine—brain cancer	0.000325	0.00336	CcSEcCtD
Nelfinavir—Erythema—Temozolomide—brain cancer	0.000325	0.00335	CcSEcCtD
Nelfinavir—Malnutrition—Temozolomide—brain cancer	0.000325	0.00335	CcSEcCtD
Nelfinavir—Jaundice—Etoposide—brain cancer	0.000324	0.00335	CcSEcCtD
Nelfinavir—Stomatitis—Etoposide—brain cancer	0.000324	0.00335	CcSEcCtD
Nelfinavir—Anorexia—Hydroxyurea—brain cancer	0.000323	0.00334	CcSEcCtD
Nelfinavir—Hypersensitivity—Procarbazine—brain cancer	0.000323	0.00333	CcSEcCtD
Nelfinavir—Asthenia—Procarbazine—brain cancer	0.000314	0.00325	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Etoposide—brain cancer	0.000314	0.00325	CcSEcCtD
Nelfinavir—Back pain—Temozolomide—brain cancer	0.000314	0.00324	CcSEcCtD
Nelfinavir—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000313	0.0145	CbGpPWpGaD
Nelfinavir—Anaemia—Carmustine—brain cancer	0.00031	0.00321	CcSEcCtD
Nelfinavir—Pruritus—Procarbazine—brain cancer	0.00031	0.0032	CcSEcCtD
Nelfinavir—Agitation—Carmustine—brain cancer	0.000309	0.00319	CcSEcCtD
Nelfinavir—Dyspnoea—Hydroxyurea—brain cancer	0.000302	0.00312	CcSEcCtD
Nelfinavir—Somnolence—Hydroxyurea—brain cancer	0.000301	0.00311	CcSEcCtD
Nelfinavir—Ill-defined disorder—Temozolomide—brain cancer	0.000301	0.00311	CcSEcCtD
Nelfinavir—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000301	0.014	CbGpPWpGaD
Nelfinavir—Leukopenia—Carmustine—brain cancer	0.000301	0.00311	CcSEcCtD
Nelfinavir—Anaemia—Temozolomide—brain cancer	0.0003	0.0031	CcSEcCtD
Nelfinavir—Diarrhoea—Procarbazine—brain cancer	0.0003	0.0031	CcSEcCtD
Nelfinavir—Dyspepsia—Hydroxyurea—brain cancer	0.000298	0.00308	CcSEcCtD
Nelfinavir—Agitation—Temozolomide—brain cancer	0.000298	0.00308	CcSEcCtD
Nelfinavir—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000298	0.0139	CbGpPWpGaD
Nelfinavir—Decreased appetite—Hydroxyurea—brain cancer	0.000295	0.00305	CcSEcCtD
Nelfinavir—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000294	0.0137	CbGpPWpGaD
Nelfinavir—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000293	0.00302	CcSEcCtD
Nelfinavir—Malaise—Temozolomide—brain cancer	0.000293	0.00302	CcSEcCtD
Nelfinavir—Convulsion—Carmustine—brain cancer	0.000291	0.00301	CcSEcCtD
Nelfinavir—Leukopenia—Temozolomide—brain cancer	0.000291	0.003	CcSEcCtD
Nelfinavir—Pain—Hydroxyurea—brain cancer	0.00029	0.003	CcSEcCtD
Nelfinavir—Dizziness—Procarbazine—brain cancer	0.00029	0.00299	CcSEcCtD
Nelfinavir—Myalgia—Carmustine—brain cancer	0.000286	0.00295	CcSEcCtD
Nelfinavir—Anxiety—Carmustine—brain cancer	0.000285	0.00294	CcSEcCtD
Nelfinavir—Erythema multiforme—Etoposide—brain cancer	0.000282	0.00291	CcSEcCtD
Nelfinavir—Convulsion—Temozolomide—brain cancer	0.000281	0.00291	CcSEcCtD
Nelfinavir—Feeling abnormal—Hydroxyurea—brain cancer	0.000279	0.00289	CcSEcCtD
Nelfinavir—Eye disorder—Etoposide—brain cancer	0.000279	0.00288	CcSEcCtD
Nelfinavir—Vomiting—Procarbazine—brain cancer	0.000279	0.00288	CcSEcCtD
Nelfinavir—Myalgia—Temozolomide—brain cancer	0.000276	0.00285	CcSEcCtD
Nelfinavir—Arthralgia—Temozolomide—brain cancer	0.000276	0.00285	CcSEcCtD
Nelfinavir—Rash—Procarbazine—brain cancer	0.000276	0.00285	CcSEcCtD
Nelfinavir—SLCO1B1—Irinotecan Pathway—APC—brain cancer	0.000276	0.0128	CbGpPWpGaD
Nelfinavir—Dermatitis—Procarbazine—brain cancer	0.000276	0.00285	CcSEcCtD
Nelfinavir—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000276	0.0128	CbGpPWpGaD
Nelfinavir—Anxiety—Temozolomide—brain cancer	0.000275	0.00284	CcSEcCtD
Nelfinavir—Headache—Procarbazine—brain cancer	0.000274	0.00284	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000274	0.00284	CcSEcCtD
Nelfinavir—Oedema—Carmustine—brain cancer	0.000274	0.00283	CcSEcCtD
Nelfinavir—Discomfort—Temozolomide—brain cancer	0.000273	0.00282	CcSEcCtD
Nelfinavir—Angiopathy—Etoposide—brain cancer	0.000271	0.0028	CcSEcCtD
Nelfinavir—Immune system disorder—Etoposide—brain cancer	0.000269	0.00278	CcSEcCtD
Nelfinavir—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000269	0.0125	CbGpPWpGaD
Nelfinavir—Thrombocytopenia—Carmustine—brain cancer	0.000268	0.00277	CcSEcCtD
Nelfinavir—Body temperature increased—Hydroxyurea—brain cancer	0.000268	0.00277	CcSEcCtD
Nelfinavir—Oedema—Temozolomide—brain cancer	0.000265	0.00274	CcSEcCtD
Nelfinavir—Anorexia—Carmustine—brain cancer	0.000261	0.0027	CcSEcCtD
Nelfinavir—Nausea—Procarbazine—brain cancer	0.00026	0.00269	CcSEcCtD
Nelfinavir—Thrombocytopenia—Temozolomide—brain cancer	0.000259	0.00268	CcSEcCtD
Nelfinavir—Skin disorder—Temozolomide—brain cancer	0.000257	0.00266	CcSEcCtD
Nelfinavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000256	0.0119	CbGpPWpGaD
Nelfinavir—Hyperhidrosis—Temozolomide—brain cancer	0.000256	0.00265	CcSEcCtD
Nelfinavir—ABCG2—Irinotecan Pathway—APC—brain cancer	0.000256	0.0119	CbGpPWpGaD
Nelfinavir—Anorexia—Temozolomide—brain cancer	0.000252	0.00261	CcSEcCtD
Nelfinavir—Back pain—Etoposide—brain cancer	0.000251	0.0026	CcSEcCtD
Nelfinavir—Hypersensitivity—Hydroxyurea—brain cancer	0.00025	0.00258	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Carmustine—brain cancer	0.00025	0.00258	CcSEcCtD
Nelfinavir—Muscle spasms—Etoposide—brain cancer	0.00025	0.00258	CcSEcCtD
Nelfinavir—Insomnia—Carmustine—brain cancer	0.000248	0.00256	CcSEcCtD
Nelfinavir—Paraesthesia—Carmustine—brain cancer	0.000246	0.00254	CcSEcCtD
Nelfinavir—Dyspnoea—Carmustine—brain cancer	0.000244	0.00252	CcSEcCtD
Nelfinavir—Somnolence—Carmustine—brain cancer	0.000244	0.00252	CcSEcCtD
Nelfinavir—Asthenia—Hydroxyurea—brain cancer	0.000243	0.00251	CcSEcCtD
Nelfinavir—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000242	0.0112	CbGpPWpGaD
Nelfinavir—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000241	0.0112	CbGpPWpGaD
Nelfinavir—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000241	0.00249	CcSEcCtD
Nelfinavir—Ill-defined disorder—Etoposide—brain cancer	0.000241	0.00249	CcSEcCtD
Nelfinavir—Anaemia—Etoposide—brain cancer	0.00024	0.00248	CcSEcCtD
Nelfinavir—Insomnia—Temozolomide—brain cancer	0.00024	0.00248	CcSEcCtD
Nelfinavir—Decreased appetite—Carmustine—brain cancer	0.000238	0.00246	CcSEcCtD
Nelfinavir—Paraesthesia—Temozolomide—brain cancer	0.000238	0.00246	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Carmustine—brain cancer	0.000237	0.00244	CcSEcCtD
Nelfinavir—Dyspnoea—Temozolomide—brain cancer	0.000236	0.00244	CcSEcCtD
Nelfinavir—Somnolence—Temozolomide—brain cancer	0.000235	0.00243	CcSEcCtD
Nelfinavir—Pain—Carmustine—brain cancer	0.000234	0.00242	CcSEcCtD
Nelfinavir—Malaise—Etoposide—brain cancer	0.000234	0.00242	CcSEcCtD
Nelfinavir—Dyspepsia—Temozolomide—brain cancer	0.000233	0.00241	CcSEcCtD
Nelfinavir—Leukopenia—Etoposide—brain cancer	0.000232	0.0024	CcSEcCtD
Nelfinavir—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000232	0.0108	CbGpPWpGaD
Nelfinavir—Diarrhoea—Hydroxyurea—brain cancer	0.000232	0.0024	CcSEcCtD
Nelfinavir—Decreased appetite—Temozolomide—brain cancer	0.00023	0.00238	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Temozolomide—brain cancer	0.000229	0.00236	CcSEcCtD
Nelfinavir—Pain—Temozolomide—brain cancer	0.000227	0.00234	CcSEcCtD
Nelfinavir—Feeling abnormal—Carmustine—brain cancer	0.000226	0.00233	CcSEcCtD
Nelfinavir—Convulsion—Etoposide—brain cancer	0.000225	0.00232	CcSEcCtD
Nelfinavir—Dizziness—Hydroxyurea—brain cancer	0.000224	0.00232	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Carmustine—brain cancer	0.000224	0.00232	CcSEcCtD
Nelfinavir—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000221	0.0103	CbGpPWpGaD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00022	0.00227	CcSEcCtD
Nelfinavir—Discomfort—Etoposide—brain cancer	0.000218	0.00226	CcSEcCtD
Nelfinavir—Feeling abnormal—Temozolomide—brain cancer	0.000218	0.00226	CcSEcCtD
Nelfinavir—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000218	0.0101	CbGpPWpGaD
Nelfinavir—Abdominal pain—Carmustine—brain cancer	0.000217	0.00224	CcSEcCtD
Nelfinavir—Body temperature increased—Carmustine—brain cancer	0.000217	0.00224	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Temozolomide—brain cancer	0.000217	0.00224	CcSEcCtD
Nelfinavir—Vomiting—Hydroxyurea—brain cancer	0.000216	0.00223	CcSEcCtD
Nelfinavir—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000216	0.01	CbGpPWpGaD
Nelfinavir—Rash—Hydroxyurea—brain cancer	0.000214	0.00221	CcSEcCtD
Nelfinavir—Dermatitis—Hydroxyurea—brain cancer	0.000214	0.00221	CcSEcCtD
Nelfinavir—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000213	0.0099	CbGpPWpGaD
Nelfinavir—Headache—Hydroxyurea—brain cancer	0.000212	0.00219	CcSEcCtD
Nelfinavir—Urticaria—Temozolomide—brain cancer	0.00021	0.00217	CcSEcCtD
Nelfinavir—Abdominal pain—Temozolomide—brain cancer	0.000209	0.00216	CcSEcCtD
Nelfinavir—Body temperature increased—Temozolomide—brain cancer	0.000209	0.00216	CcSEcCtD
Nelfinavir—Thrombocytopenia—Etoposide—brain cancer	0.000208	0.00214	CcSEcCtD
Nelfinavir—Skin disorder—Etoposide—brain cancer	0.000206	0.00213	CcSEcCtD
Nelfinavir—Hyperhidrosis—Etoposide—brain cancer	0.000205	0.00212	CcSEcCtD
Nelfinavir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000205	0.00952	CbGpPWpGaD
Nelfinavir—Anorexia—Etoposide—brain cancer	0.000202	0.00209	CcSEcCtD
Nelfinavir—Hypersensitivity—Carmustine—brain cancer	0.000202	0.00209	CcSEcCtD
Nelfinavir—Nausea—Hydroxyurea—brain cancer	0.000201	0.00208	CcSEcCtD
Nelfinavir—Asthenia—Carmustine—brain cancer	0.000197	0.00203	CcSEcCtD
Nelfinavir—Hypersensitivity—Temozolomide—brain cancer	0.000195	0.00202	CcSEcCtD
Nelfinavir—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000194	0.00902	CbGpPWpGaD
Nelfinavir—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000193	0.00897	CbGpPWpGaD
Nelfinavir—Paraesthesia—Etoposide—brain cancer	0.00019	0.00197	CcSEcCtD
Nelfinavir—Asthenia—Temozolomide—brain cancer	0.00019	0.00196	CcSEcCtD
Nelfinavir—Dyspnoea—Etoposide—brain cancer	0.000189	0.00195	CcSEcCtD
Nelfinavir—Somnolence—Etoposide—brain cancer	0.000188	0.00195	CcSEcCtD
Nelfinavir—Diarrhoea—Carmustine—brain cancer	0.000188	0.00194	CcSEcCtD
Nelfinavir—Pruritus—Temozolomide—brain cancer	0.000187	0.00194	CcSEcCtD
Nelfinavir—Decreased appetite—Etoposide—brain cancer	0.000184	0.0019	CcSEcCtD
Nelfinavir—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000183	0.00852	CbGpPWpGaD
Nelfinavir—Gastrointestinal disorder—Etoposide—brain cancer	0.000183	0.00189	CcSEcCtD
Nelfinavir—Dizziness—Carmustine—brain cancer	0.000181	0.00187	CcSEcCtD
Nelfinavir—Pain—Etoposide—brain cancer	0.000181	0.00187	CcSEcCtD
Nelfinavir—Diarrhoea—Temozolomide—brain cancer	0.000181	0.00187	CcSEcCtD
Nelfinavir—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000179	0.00832	CbGpPWpGaD
Nelfinavir—ABCG2—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.000177	0.00821	CbGpPWpGaD
Nelfinavir—Dizziness—Temozolomide—brain cancer	0.000175	0.00181	CcSEcCtD
Nelfinavir—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000175	0.00813	CbGpPWpGaD
Nelfinavir—Feeling abnormal—Etoposide—brain cancer	0.000175	0.0018	CcSEcCtD
Nelfinavir—Vomiting—Carmustine—brain cancer	0.000174	0.0018	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Etoposide—brain cancer	0.000173	0.00179	CcSEcCtD
Nelfinavir—Rash—Carmustine—brain cancer	0.000173	0.00179	CcSEcCtD
Nelfinavir—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000173	0.00804	CbGpPWpGaD
Nelfinavir—Dermatitis—Carmustine—brain cancer	0.000173	0.00178	CcSEcCtD
Nelfinavir—Headache—Carmustine—brain cancer	0.000172	0.00177	CcSEcCtD
Nelfinavir—Vomiting—Temozolomide—brain cancer	0.000168	0.00174	CcSEcCtD
Nelfinavir—Urticaria—Etoposide—brain cancer	0.000168	0.00174	CcSEcCtD
Nelfinavir—Body temperature increased—Etoposide—brain cancer	0.000168	0.00173	CcSEcCtD
Nelfinavir—Abdominal pain—Etoposide—brain cancer	0.000168	0.00173	CcSEcCtD
Nelfinavir—Rash—Temozolomide—brain cancer	0.000167	0.00173	CcSEcCtD
Nelfinavir—Dermatitis—Temozolomide—brain cancer	0.000167	0.00172	CcSEcCtD
Nelfinavir—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000167	0.00775	CbGpPWpGaD
Nelfinavir—Headache—Temozolomide—brain cancer	0.000166	0.00171	CcSEcCtD
Nelfinavir—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000166	0.00771	CbGpPWpGaD
Nelfinavir—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000164	0.00765	CbGpPWpGaD
Nelfinavir—Nausea—Carmustine—brain cancer	0.000163	0.00168	CcSEcCtD
Nelfinavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000158	0.00734	CbGpPWpGaD
Nelfinavir—Nausea—Temozolomide—brain cancer	0.000157	0.00163	CcSEcCtD
Nelfinavir—Hypersensitivity—Etoposide—brain cancer	0.000156	0.00161	CcSEcCtD
Nelfinavir—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000153	0.00713	CbGpPWpGaD
Nelfinavir—Asthenia—Etoposide—brain cancer	0.000152	0.00157	CcSEcCtD
Nelfinavir—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000151	0.00704	CbGpPWpGaD
Nelfinavir—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00015	0.00699	CbGpPWpGaD
Nelfinavir—Pruritus—Etoposide—brain cancer	0.00015	0.00155	CcSEcCtD
Nelfinavir—Diarrhoea—Etoposide—brain cancer	0.000145	0.0015	CcSEcCtD
Nelfinavir—Dizziness—Etoposide—brain cancer	0.00014	0.00145	CcSEcCtD
Nelfinavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000135	0.00629	CbGpPWpGaD
Nelfinavir—Vomiting—Etoposide—brain cancer	0.000135	0.00139	CcSEcCtD
Nelfinavir—Rash—Etoposide—brain cancer	0.000134	0.00138	CcSEcCtD
Nelfinavir—Dermatitis—Etoposide—brain cancer	0.000134	0.00138	CcSEcCtD
Nelfinavir—Headache—Etoposide—brain cancer	0.000133	0.00137	CcSEcCtD
Nelfinavir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00013	0.00604	CbGpPWpGaD
Nelfinavir—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000128	0.00597	CbGpPWpGaD
Nelfinavir—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000128	0.00596	CbGpPWpGaD
Nelfinavir—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000127	0.00589	CbGpPWpGaD
Nelfinavir—Nausea—Etoposide—brain cancer	0.000126	0.0013	CcSEcCtD
Nelfinavir—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000124	0.00578	CbGpPWpGaD
Nelfinavir—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000121	0.00563	CbGpPWpGaD
Nelfinavir—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000105	0.0049	CbGpPWpGaD
Nelfinavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000105	0.00488	CbGpPWpGaD
Nelfinavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.0001	0.00466	CbGpPWpGaD
Nelfinavir—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	9.89e-05	0.0046	CbGpPWpGaD
Nelfinavir—CYP2B6—Biological oxidations—CYP2C9—brain cancer	9.5e-05	0.00442	CbGpPWpGaD
Nelfinavir—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	9.37e-05	0.00436	CbGpPWpGaD
Nelfinavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	9.34e-05	0.00435	CbGpPWpGaD
Nelfinavir—CYP3A5—Biological oxidations—CYP2C9—brain cancer	9.28e-05	0.00432	CbGpPWpGaD
Nelfinavir—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	9.16e-05	0.00426	CbGpPWpGaD
Nelfinavir—CYP3A4—Irinotecan Pathway—APC—brain cancer	8.51e-05	0.00396	CbGpPWpGaD
Nelfinavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	8.13e-05	0.00378	CbGpPWpGaD
Nelfinavir—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	7.55e-05	0.00351	CbGpPWpGaD
Nelfinavir—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	7.52e-05	0.0035	CbGpPWpGaD
Nelfinavir—SLCO1A2—Transmembrane transport of small molecules—S100A10—brain cancer	7.21e-05	0.00335	CbGpPWpGaD
Nelfinavir—CYP2C19—Biological oxidations—CYP2C9—brain cancer	7.18e-05	0.00334	CbGpPWpGaD
Nelfinavir—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	7.08e-05	0.00329	CbGpPWpGaD
Nelfinavir—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	6.93e-05	0.00322	CbGpPWpGaD
Nelfinavir—CYP2D6—Biological oxidations—CYP2C9—brain cancer	6.6e-05	0.00307	CbGpPWpGaD
Nelfinavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	6.54e-05	0.00304	CbGpPWpGaD
Nelfinavir—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	6.51e-05	0.00303	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.28e-05	0.00292	CbGpPWpGaD
Nelfinavir—SLCO1B1—Transmembrane transport of small molecules—S100A10—brain cancer	6.17e-05	0.00287	CbGpPWpGaD
Nelfinavir—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	5.82e-05	0.00271	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	5.77e-05	0.00268	CbGpPWpGaD
Nelfinavir—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	5.71e-05	0.00266	CbGpPWpGaD
Nelfinavir—CYP1A2—Biological oxidations—CYP2C9—brain cancer	5.59e-05	0.0026	CbGpPWpGaD
Nelfinavir—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	5.52e-05	0.00257	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.37e-05	0.0025	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmembrane transport of small molecules—S100A10—brain cancer	5.27e-05	0.00245	CbGpPWpGaD
Nelfinavir—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	5.16e-05	0.0024	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.59e-05	0.00214	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—PDGFRA—brain cancer	4.46e-05	0.00208	CbGpPWpGaD
Nelfinavir—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	4.42e-05	0.00206	CbGpPWpGaD
Nelfinavir—CYP3A4—Biological oxidations—CYP2C9—brain cancer	4.32e-05	0.00201	CbGpPWpGaD
Nelfinavir—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	4.26e-05	0.00198	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.93e-05	0.00183	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	3.72e-05	0.00173	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	3.53e-05	0.00164	CbGpPWpGaD
Nelfinavir—SLCO1A2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.33e-05	0.00155	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	3.33e-05	0.00155	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	3.09e-05	0.00144	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	3e-05	0.00139	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	2.98e-05	0.00139	CbGpPWpGaD
Nelfinavir—SLCO1B1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.85e-05	0.00132	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—CYP2C9—brain cancer	2.8e-05	0.0013	CbGpPWpGaD
Nelfinavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	2.79e-05	0.0013	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.76e-05	0.00128	CbGpPWpGaD
Nelfinavir—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.64e-05	0.00123	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	2.55e-05	0.00118	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	2.45e-05	0.00114	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—IL2—brain cancer	2.44e-05	0.00113	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.43e-05	0.00113	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	2.4e-05	0.00112	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—CYP2C9—brain cancer	2.39e-05	0.00111	CbGpPWpGaD
Nelfinavir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	2.39e-05	0.00111	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—BSG—brain cancer	2.38e-05	0.00111	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	2.37e-05	0.0011	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	2.34e-05	0.00109	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2.29e-05	0.00107	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	2.29e-05	0.00107	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CYP2C9—brain cancer	2.22e-05	0.00103	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	2.2e-05	0.00102	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CYP2C9—brain cancer	2.2e-05	0.00102	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.15e-05	0.000999	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.1e-05	0.000976	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.07e-05	0.000963	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—IDH1—brain cancer	2.05e-05	0.000952	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CYP2C9—brain cancer	2.04e-05	0.000951	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—BSG—brain cancer	2.03e-05	0.000947	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.02e-05	0.000937	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—BSG—brain cancer	1.88e-05	0.000876	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—BSG—brain cancer	1.87e-05	0.000869	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.84e-05	0.000855	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.81e-05	0.000844	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—IDH1—brain cancer	1.75e-05	0.000814	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—BSG—brain cancer	1.74e-05	0.000808	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.71e-05	0.000795	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.67e-05	0.000775	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CYP2C9—brain cancer	1.62e-05	0.000756	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—IDH1—brain cancer	1.62e-05	0.000754	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—ENO2—brain cancer	1.62e-05	0.000752	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—IDH1—brain cancer	1.61e-05	0.000747	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP2C9—brain cancer	1.59e-05	0.000739	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.57e-05	0.00073	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—IDH1—brain cancer	1.49e-05	0.000695	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.43e-05	0.000663	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.42e-05	0.000663	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—ENO2—brain cancer	1.38e-05	0.000643	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—BSG—brain cancer	1.38e-05	0.000642	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—BSG—brain cancer	1.35e-05	0.000628	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.33e-05	0.000617	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—ENO2—brain cancer	1.28e-05	0.000596	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—ENO2—brain cancer	1.27e-05	0.000591	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP2C9—brain cancer	1.23e-05	0.000571	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP2C9—brain cancer	1.2e-05	0.000557	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—IDH1—brain cancer	1.19e-05	0.000552	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—ENO2—brain cancer	1.18e-05	0.00055	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.17e-05	0.000545	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—IDH1—brain cancer	1.16e-05	0.00054	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.16e-05	0.00054	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP2C9—brain cancer	1.13e-05	0.000525	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—BSG—brain cancer	1.04e-05	0.000486	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.02e-05	0.000475	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—BSG—brain cancer	1.02e-05	0.000474	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—BSG—brain cancer	9.6e-06	0.000447	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP2C9—brain cancer	9.56e-06	0.000445	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—BSG—brain cancer	9.52e-06	0.000443	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	9.4e-06	0.000437	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ENO2—brain cancer	9.39e-06	0.000437	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	9.19e-06	0.000428	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ENO2—brain cancer	9.18e-06	0.000427	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—IDH1—brain cancer	8.97e-06	0.000417	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—IDH1—brain cancer	8.76e-06	0.000407	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—IDH1—brain cancer	8.25e-06	0.000384	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—IDH1—brain cancer	8.18e-06	0.000381	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—BSG—brain cancer	8.13e-06	0.000378	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	7.72e-06	0.000359	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CG—brain cancer	7.42e-06	0.000345	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP2C9—brain cancer	7.38e-06	0.000343	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.31e-06	0.00034	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ENO2—brain cancer	7.09e-06	0.00033	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—IDH1—brain cancer	6.99e-06	0.000325	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ENO2—brain cancer	6.92e-06	0.000322	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.66e-06	0.00031	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ENO2—brain cancer	6.53e-06	0.000304	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ENO2—brain cancer	6.47e-06	0.000301	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CG—brain cancer	6.35e-06	0.000295	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—BSG—brain cancer	6.28e-06	0.000292	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CG—brain cancer	5.88e-06	0.000273	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CG—brain cancer	5.82e-06	0.000271	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.69e-06	0.000265	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ENO2—brain cancer	5.53e-06	0.000257	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CG—brain cancer	5.42e-06	0.000252	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—IDH1—brain cancer	5.4e-06	0.000251	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CG—brain cancer	4.31e-06	0.0002	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ENO2—brain cancer	4.27e-06	0.000198	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CG—brain cancer	4.21e-06	0.000196	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CG—brain cancer	3.25e-06	0.000151	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CG—brain cancer	3.18e-06	0.000148	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CG—brain cancer	2.99e-06	0.000139	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CG—brain cancer	2.97e-06	0.000138	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CG—brain cancer	2.54e-06	0.000118	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CG—brain cancer	1.96e-06	9.1e-05	CbGpPWpGaD
